« Back
Home /
LY2510924

LY2510924

Manufacturer	MedChem Express
Category	Oncology Neuroscience Neural Lineage Markers Neuroinflammation Neural Signaling Inhibitors & Compound Libraries Small Molecules By Organ Skin Cancer Lymphatic System Cancer
Type	Inhibitors
Specific against	other
Amount	10mM/1mL
Item no.	HY-12488-10mM
Targets	CXCR
CASRN	1088715-84-7
eClass 6.1	30220300
eClass 9.0	32160605
Available
Product Description	LY2510924 is a potent and selective CXCR4 antagonist that blocks SDF-1 binding to CXCR4 with an IC50 of 0.079 nM.
StorageTemperature	-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture and light, under nitrogen)
Shipping	Blue Ice
Manufacturers Applications	Cancer-programmed cell death
MolecularWeight	1189.45
Clinical_Information	Phase 2
Manufacturers Research_Area	Cancer; Endocrinology
Solubility	DMSO : ≥ 125 mg/mL\|H2O : ≥ 100 mg/mL
Manufacturers Target	CXCR
Isoform	CXCR4
Pathway	GPCR/G Protein; Immunology/Inflammation
Manufacturers Product type	Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

HY-12488-10mM-safety-datasheet.pdf